{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:28:30Z","timestamp":1792099710145,"version":"4.4.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Agricultural Research Developmental Agency (ARDA), Bangkok, Thailand."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12640-017-9860-4","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T05:22:55Z","timestamp":1515648175000},"page":"621-633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study"],"prefix":"10.1007","volume":"33","author":[{"given":"Buranee","family":"Kanchanatawan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sookjaroen","family":"Tangwongchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atapol","family":"Sughondhabhirom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriluck","family":"Suppapitiporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solaphat","family":"Hemrunrojn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-871X","authenticated-orcid":false,"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"issue":"2","key":"9860_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ptr.5524","volume":"30","author":"D Al-Karawi","year":"2016","unstructured":"Al-Karawi D, Al Mamoori DA, Tayyar Y (2016) The role of curcumin administration in patients with major depressive disorder: Mini meta-analysis of clinical trials. Phytother Res 30(2):175\u2013183. https:\/\/doi.org\/10.1002\/ptr.5524","journal-title":"Phytother Res"},{"issue":"1","key":"9860_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/18715273113129990082","volume":"13","author":"G Anderson","year":"2014","unstructured":"Anderson G, Maes M (2014) TRYCAT pathways link peripheral inflammation, nicotine, somatization and depression in the etiology and course of Parkinson's disease. CNS Neurol Disord Drug Targets 13(1):137\u2013149. https:\/\/doi.org\/10.2174\/18715273113129990082","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"9860_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2013.03.023","volume":"1515","author":"D Banji","year":"2013","unstructured":"Banji D, Banji OJ, Dasaroju S, Kranthi KC (2013) Curcumin and piperine abrogate lipid and protein oxidation induced by D-galactose in rat brain. Brain Res 1515:1\u201311. https:\/\/doi.org\/10.1016\/j.brainres.2013.03.023","journal-title":"Brain Res"},{"issue":"12","key":"9860_CR4","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/jama.2010.310","volume":"303","author":"D Bassler","year":"2010","unstructured":"Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH, STOPIT-2 Study Group, Flynn DN, Elamin MB, Murad MH, Abu Elnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R, Ruiz Culebro C, You JJ, Mulla SM, Kaur J, Nerenberg KA, Sch\u00fcnemann H, Cook DJ, Lutz K, Ribic CM, Vale N, Malaga G, Akl EA, Ferreira-Gonzalez I, Alonso-Coello P, Urrutia G, Kunz R, Bucher HC, Nordmann AJ, Raatz H, da Silva SA, Tuche F, Strahm B, Djulbegovic B, Adhikari NK, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Karanicolas PJ, Burns KE, Vandvik PO, Coto-Yglesias F, Chrispim PP, Ramsay T (2010) Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 303(12):1180\u20131187. https:\/\/doi.org\/10.1001\/jama.2010.310","journal-title":"JAMA"},{"issue":"1","key":"9860_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","volume":"64","author":"M Bilici","year":"2001","unstructured":"Bilici M, Efe H, K\u00f6ro\u011flu MA, Uydu HA, Bekaro\u011flu M, De\u011fer O (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64(1):43\u201351. https:\/\/doi.org\/10.1016\/S0165-0327(00)00199-3","journal-title":"J Affect Disord"},{"key":"9860_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jad.2014.02.018","volume":"159","author":"CC Bortolasci","year":"2014","unstructured":"Bortolasci CC, Vargas HO, Souza-Nogueira A, Barbosa DS, Moreira EG, Nunes SO, Berk M, Dodd S, Maes M (2014) Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. J Affect Disord 159:23\u201330. https:\/\/doi.org\/10.1016\/j.jad.2014.02.018","journal-title":"J Affect Disord"},{"issue":"2","key":"9860_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000357500","volume":"83","author":"AF Carvalho","year":"2014","unstructured":"Carvalho AF, Berk M, Hyphantis TN, McIntyre RS (2014) The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychother Psychosom 83(2):70\u201388. https:\/\/doi.org\/10.1159\/000357500","journal-title":"Psychother Psychosom"},{"issue":"5","key":"9860_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/jemt.22485","volume":"78","author":"G Ciftci","year":"2015","unstructured":"Ciftci G, Aksoy A, Cenesiz S, Sogut MU, Yarim GF, Nisbet C, Guvenc D, Ertekin A (2015) Therapeutic role of curcumin in oxidative DNA damage caused by formaldehyde. Microsc Res Tech 78(5):391\u2013395. https:\/\/doi.org\/10.1002\/jemt.22485","journal-title":"Microsc Res Tech"},{"key":"9860_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pnpbp.2017.04.027","volume":"78","author":"LGP Melo de","year":"2017","unstructured":"de Melo LGP, Nunes SOV, Anderson G, Vargas HO, Barbosa DS, Galecki P, Carvalho AF, Maes M (2017) Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders. Prog Neuro-Psychopharmacol Biol Psychiatry 78:34\u201350. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.04.027","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"5","key":"9860_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.biotechadv.2016.04.004","volume":"34","author":"MR Oliveira de","year":"2016","unstructured":"de Oliveira MR, Jardim FR, Setzer WN, Nabavi SM, Nabavi SF (2016) Curcumin, mitochondrial biogenesis, and mitophagy: exploring recent data and indicating future needs. Biotechnol Adv 34(5):813\u2013826. https:\/\/doi.org\/10.1016\/j.biotechadv.2016.04.004","journal-title":"Biotechnol Adv"},{"issue":"5","key":"9860_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s11655-015-2160-z","volume":"21","author":"H Esmaily","year":"2015","unstructured":"Esmaily H, Sahebkar A, Iranshahi M, Ganjali S, Mohammadi A, Ferns G, Ghayour-Mobarhan M (2015) An investigation of the effects of curcumin on anxiety and depression in obese individuals: a randomized controlled trial. Chin J Integr Med 21(5):332\u2013338. https:\/\/doi.org\/10.1007\/s11655-015-2160-z","journal-title":"Chin J Integr Med"},{"key":"9860_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-15889-1","volume-title":"Therapeutic potentials of curcumin for Alzheimer disease","author":"AA Farooqui","year":"2016","unstructured":"Farooqui AA (2016) Therapeutic potentials of curcumin for Alzheimer disease. Springer, Berlin. https:\/\/doi.org\/10.1007\/978-3-319-15889-1"},{"issue":"3","key":"9860_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jad.2012.01.016","volume":"138","author":"P Ga\u0142ecki","year":"2012","unstructured":"Ga\u0142ecki P, Ga\u0142ecka E, Maes M, Chamielec M, Orzechowska A, Bobi\u0144ska K, Lewi\u0144ski A, Szemraj J (2012) The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. J Affect Disord 138(3):360\u2013366. https:\/\/doi.org\/10.1016\/j.jad.2012.01.016","journal-title":"J Affect Disord"},{"key":"9860_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.phrs.2017.02.008","volume":"119","author":"S Ganjali","year":"2017","unstructured":"Ganjali S, Blesso CN, Banach M, Pirro M, Majeed M, Sahebkar A (2017) Effects of curcumin on HDL functionality. Pharmacol Res 119:208\u2013218. https:\/\/doi.org\/10.1016\/j.phrs.2017.02.008","journal-title":"Pharmacol Res"},{"issue":"6","key":"9860_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2174\/1381612822666161006151605","volume":"23","author":"M Ghandadi","year":"2017","unstructured":"Ghandadi M, Sahebkar A (2017) Curcumin: an effective inhibitor of interleukin-6. Curr Pharm Des 23(6):921\u2013931. https:\/\/doi.org\/10.2174\/1381612822666161006151605","journal-title":"Curr Pharm Des"},{"key":"9860_CR16","doi-asserted-by":"publisher","unstructured":"Gomes C, Martinho FC, Barbosa DS, Antunes LS, P\u00f3voa HCC, Baltus THL, Morelli NR, Vargas HO, Nunes SOV, Anderson G, Maes M (2017) Increased root canal endotoxin levels are associated with chronic apical periodontitis, increased oxidative and nitrosative stress, major depression, severity of depression, and a lowered quality of life. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-017-0545-z","DOI":"10.1007\/s12035-017-0545-z"},{"key":"9860_CR17","first-page":"801418","volume":"2013","author":"S Gonz\u00e1lez-Reyes","year":"2013","unstructured":"Gonz\u00e1lez-Reyes S, Guzm\u00e1n-Beltr\u00e1n S, Medina-Campos ON, Pedraza-Chaverri J (2013) Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats. Oxidative Med Cell 2013:801418","journal-title":"Oxidative Med Cell"},{"issue":"1","key":"9860_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32(1):50\u201355. https:\/\/doi.org\/10.1111\/j.2044-8341.1959.tb00467.x","journal-title":"Br J Med Psychol"},{"key":"9860_CR19","doi-asserted-by":"publisher","unstructured":"Hewlings SJ, Kalman DS (2017) Curcumin: a review of Its\u2019 effects on human health. Foods 6(10). https:\/\/doi.org\/10.3390\/foods6100092","DOI":"10.3390\/foods6100092"},{"issue":"2","key":"9860_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71(2):171\u2013186. https:\/\/doi.org\/10.1097\/PSY.0b013e3181907c1b","journal-title":"Psychosom Med"},{"issue":"6","key":"9860_CR21","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1074\/jbc.M807328200","volume":"284","author":"YI Jeong","year":"2009","unstructured":"Jeong YI, Kim SW, Jung ID, Lee JS, Chang JH, Lee CM, Chun SH, Yoon MS, Kim GT, Ryu SW, Kim JS, Shin YK, Lee WS, Shin HK, Lee JD, Park YM (2009) Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells. J Biol Chem 284(6):3700\u20133708. https:\/\/doi.org\/10.1074\/jbc.M807328200","journal-title":"J Biol Chem"},{"issue":"8","key":"9860_CR22","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/jn\/135.8.1859","volume":"135","author":"N Jurrmann","year":"2005","unstructured":"Jurrmann N, Brigelius-Floh\u00e9 R, B\u00f6l GF (2005) Curcumin blocks interleukin-1 (IL-1) signaling by inhibiting the recruitment of the IL-1 receptor-associated kinase IRAK in murine thymoma EL-4 cells. J Nutr 135(8):1859\u20131864","journal-title":"J Nutr"},{"key":"9860_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejphar.2016.05.026","volume":"784","author":"FN Kaufmann","year":"2016","unstructured":"Kaufmann FN, Gazal M, Bastos CR, Kaster MP, Ghisleni G (2016) Curcumin in depressive disorders: an overview of potential mechanisms, preclinical and clinical findings. Eur J Pharmacol 784:192\u2013198. https:\/\/doi.org\/10.1016\/j.ejphar.2016.05.026","journal-title":"Eur J Pharmacol"},{"key":"9860_CR24","unstructured":"Kittirathanapaiboon P, Khamwongpin M (2005) The validity of the Mini International Neuropsychiatric Interview (M.I.N.I.) Thai version. Suanprung Hospital, Department of Mental Health"},{"issue":"12","key":"9860_CR25","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","volume":"71","author":"O K\u00f6hler","year":"2014","unstructured":"K\u00f6hler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, Krogh J (2014) Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71(12):1381\u20131391. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1611","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"9860_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA K\u00f6hler","year":"2017","unstructured":"K\u00f6hler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, Raison CL, Miller BJ, Lanct\u00f4t KL, Carvalho AF (2017a) Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 135(5):373\u2013387. https:\/\/doi.org\/10.1111\/acps.12698","journal-title":"Acta Psychiatr Scand"},{"key":"9860_CR27","doi-asserted-by":"publisher","unstructured":"K\u00f6hler CA, Freitas TH, Stubbs B, Maes M, Solmi M, Veronese N, de Andrade NQ, Morris G, Fernandes BS, Brunoni AR, Herrmann N, Raison CL, Miller BJ, Lanct\u00f4t KL, Carvalho AF (2017b) Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-017-0632-1","DOI":"10.1007\/s12035-017-0632-1"},{"issue":"2","key":"9860_CR28","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","volume":"36","author":"B Leonard","year":"2012","unstructured":"Leonard B, Maes M (2012) Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 36(2):764\u2013785. https:\/\/doi.org\/10.1016\/j.neubiorev.2011.12.005","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"9860_CR29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","volume":"139","author":"Y Liu","year":"2012","unstructured":"Liu Y, Ho RC, Mak A (2012) Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord 139(3):230\u2013239. https:\/\/doi.org\/10.1016\/j.jad.2011.08.003","journal-title":"J Affect Disord"},{"issue":"10","key":"9860_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138904","volume":"10","author":"T Liu","year":"2015","unstructured":"Liu T, Zhong S, Liao X, Chen J, He T, Lai S, Jia Y (2015) A meta-analysis of oxidative stress markers in depression. PLoS One 10(10):e0138904. https:\/\/doi.org\/10.1371\/journal.pone.0138904","journal-title":"PLoS One"},{"issue":"3","key":"9860_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/0269881116686883","volume":"31","author":"AL Lopresti","year":"2017","unstructured":"Lopresti AL (2017) Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies. J Psychopharmacol 31(3):287\u2013302. https:\/\/doi.org\/10.1177\/0269881116686883","journal-title":"J Psychopharmacol"},{"key":"9860_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jad.2016.09.047","volume":"207","author":"AL Lopresti","year":"2017","unstructured":"Lopresti AL, Drummond PD (2017) Efficacy of curcumin, and a saffron\/curcumin combination for the treatment of major depression: a randomised, double-blind, placebo-controlled study. J Affect Disord 207:188\u2013196. https:\/\/doi.org\/10.1016\/j.jad.2016.09.047","journal-title":"J Affect Disord"},{"issue":"12","key":"9860_CR33","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1177\/0269881112458732","volume":"26","author":"AL Lopresti","year":"2012","unstructured":"Lopresti AL, Hood SD, Drummond PD (2012) Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects. J Psychopharmacol 26(12):1512\u20131524. https:\/\/doi.org\/10.1177\/0269881112458732","journal-title":"J Psychopharmacol"},{"key":"9860_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jad.2014.06.001","volume":"167","author":"AL Lopresti","year":"2014","unstructured":"Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD (2014) Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord 167:368\u2013375. https:\/\/doi.org\/10.1016\/j.jad.2014.06.001","journal-title":"J Affect Disord"},{"issue":"1","key":"9860_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.euroneuro.2014.11.015","volume":"25","author":"AL Lopresti","year":"2015","unstructured":"Lopresti AL, Maes M, Meddens MJ, Maker GL, Arnoldussen E, Drummond PD (2015) Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change. Eur Neuropsychopharmacol 25(1):38\u201350. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.11.015","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"9860_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","volume":"19","author":"M Maes","year":"1995","unstructured":"Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuro-Psychopharmacol Biol Psychiatry 19(1):11\u201338. https:\/\/doi.org\/10.1016\/0278-5846(94)00101-M","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9860_CR37","unstructured":"Maes M (2005) Van Freud tot omega-3, 2005. Standaard Uitgeverij, Antwerpen, 240 pagina's, 9789002214813"},{"issue":"3","key":"9860_CR38","first-page":"287","volume":"29","author":"M Maes","year":"2008","unstructured":"Maes M (2008) The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 29(3):287\u2013291","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"9860_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000119472","volume":"24","author":"M Maes","year":"1990","unstructured":"Maes M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus J (1990) Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 24(3):115\u2013120. https:\/\/doi.org\/10.1159\/000119472","journal-title":"Neuropsychobiology"},{"issue":"4","key":"9860_CR40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-0447.1994.tb01589.x","volume":"90","author":"M Maes","year":"1994","unstructured":"Maes M, Delanghe J, Meltzer HY, Scharp\u00e9 S, D'Hondt P, Cosyns P (1994) Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research. Acta Psychiatr Scand 90(4):252\u2013258. https:\/\/doi.org\/10.1111\/j.1600-0447.1994.tb01589.x","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"9860_CR41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0447.1997.tb09622.x","volume":"95","author":"M Maes","year":"1997","unstructured":"Maes M, Smith R, Christophe A, Vandoolaeghe E, Van Gastel A, Neels H, Demedts P, Wauters A, Meltzer HY (1997) Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand 95(3):212\u2013221","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"9860_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0165-1781(99)00014-1","volume":"85","author":"M Maes","year":"1999","unstructured":"Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY (1999) Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 85(3):275\u2013291. https:\/\/doi.org\/10.1016\/S0165-1781(99)00014-1","journal-title":"Psychiatry Res"},{"issue":"3","key":"9860_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0165-0327(99)00121-4","volume":"58","author":"M Maes","year":"2000","unstructured":"Maes M, De Vos N, Pioli R, Demedts P, Wauters A, Neels H, Christophe A (2000) Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord 58(3):241\u2013246. https:\/\/doi.org\/10.1016\/S0165-0327(99)00121-4","journal-title":"J Affect Disord"},{"issue":"1","key":"9860_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","volume":"24","author":"M Maes","year":"2009","unstructured":"Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M (2009) The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24(1):27\u201353. https:\/\/doi.org\/10.1007\/s11011-008-9118-1","journal-title":"Metab Brain Dis"},{"issue":"3","key":"9860_CR45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Galecki P, Chang YS, Berk M (2011a) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuro-Psychopharmacol Biol Psychiatry 35(3):676\u2013692. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.05.004","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"3","key":"9860_CR46","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011b) The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 35(3):702\u2013721","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1\u20133","key":"9860_CR47","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jad.2011.08.023","volume":"135","author":"M Maes","year":"2011","unstructured":"Maes M, Mihaylova I, Kubera M, Leunis JC, Geffard M (2011c) IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology. J Affect Disord 135(1\u20133):414\u2013418. https:\/\/doi.org\/10.1016\/j.jad.2011.08.023","journal-title":"J Affect Disord"},{"issue":"3","key":"9860_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10787-011-0111-7","volume":"20","author":"M Maes","year":"2012","unstructured":"Maes M, Fi\u0161ar Z, Medina M, Scapagnini G, Nowak G, Berk M (2012) New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 20(3):127\u2013150. https:\/\/doi.org\/10.1007\/s10787-011-0111-7","journal-title":"Inflammopharmacology"},{"issue":"4","key":"9860_CR49","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Brit J Psychiatry 134(4):382\u2013389. https:\/\/doi.org\/10.1192\/bjp.134.4.382","journal-title":"Brit J Psychiatry"},{"issue":"5","key":"9860_CR50","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/mp.2012.33","volume":"18","author":"S Moylan","year":"2013","unstructured":"Moylan S, Maes M, Wray NR, Berk M (2013) The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 18(5):595\u2013606. https:\/\/doi.org\/10.1038\/mp.2012.33","journal-title":"Mol Psychiatry"},{"issue":"6","key":"9860_CR51","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jamda.2016.12.071","volume":"18","author":"QX Ng","year":"2017","unstructured":"Ng QX, Koh SSH, Chan HW, Ho CYX (2017) Clinical use of curcumin in depression: a meta-analysis. J Am Med Dir Assoc 18(6):503\u2013508. https:\/\/doi.org\/10.1016\/j.jamda.2016.12.071","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"9860_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ptr.5211","volume":"29","author":"Y Panahi","year":"2015","unstructured":"Panahi Y, Badeli R, Karami GR, Sahebkar A (2015) Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytother Res 29(1):17\u201321. https:\/\/doi.org\/10.1002\/ptr.5211","journal-title":"Phytother Res"},{"issue":"5","key":"9860_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0006-3223(97)00206-0","volume":"43","author":"M Peet","year":"1998","unstructured":"Peet M, Murphy B, Shay J, Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43(5):315\u2013319. https:\/\/doi.org\/10.1016\/S0006-3223(97)00206-0","journal-title":"Biol Psychiatry"},{"issue":"16","key":"9860_CR54","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1001\/jama.289.16.2128","volume":"289","author":"BM Psaty","year":"2003","unstructured":"Psaty BM, Rennie D (2003) Stopping medical research to save money: a broken pact with researchers and patients. JAMA 289(16):2128\u20132131. https:\/\/doi.org\/10.1001\/jama.289.16.2128","journal-title":"JAMA"},{"key":"9860_CR55","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.psychres.2016.04.049","volume":"240","author":"HS Rizavi","year":"2016","unstructured":"Rizavi HS, Ren X, Zhang H, Bhaumik R, Pandey GN (2016) Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients. Psychiatry Res 240:314\u2013320. https:\/\/doi.org\/10.1016\/j.psychres.2016.04.049","journal-title":"Psychiatry Res"},{"key":"9860_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jad.2017.07.002","volume":"223","author":"C Roomruangwong","year":"2017","unstructured":"Roomruangwong C, Barbosa DS, Matsumoto AK, Nogueira AS, Kanchanatawan B, Sirivichayakul S, Carvalho AF, Duleu S, Geffard M, Moreira EG, Maes M (2017) Activated neuro-oxidative and neuro-nitrosative pathways at the end of term are associated with inflammation and physio-somatic and depression symptoms, while predicting outcome characteristics in mother and baby. J Affect Disord 223:49\u201358. https:\/\/doi.org\/10.1016\/j.jad.2017.07.002","journal-title":"J Affect Disord"},{"issue":"4","key":"9860_CR57","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ptr.5025","volume":"28","author":"J Sanmukhani","year":"2014","unstructured":"Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, Goel A, Tripathi CB (2014) Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res 28(4):579\u2013585. https:\/\/doi.org\/10.1002\/ptr.5025","journal-title":"Phytother Res"},{"issue":"Suppl 20","key":"9860_CR58","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22\u201323","journal-title":"J Clin Psychiatry"},{"key":"9860_CR59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neubiorev.2016.02.002","volume":"64","author":"A Slyepchenko","year":"2016","unstructured":"Slyepchenko A, Maes M, K\u00f6hler CA, Anderson G, Quevedo J, Alves GS, Berk M, Fernandes BS, Carvalho AF (2016) T helper 17 cells may drive neuroprogression in major depressive disorder: proposal of an integrative model. Neurosci Biobehav Rev 64:83\u2013100. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.02.002","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"9860_CR60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1017\/S0033291703001090","volume":"34","author":"S Sobczak","year":"2004","unstructured":"Sobczak S, Honig A, Christophe A, Maes M, Helsdingen RW, De Vriese SA, Riedel WJ (2004) Lower high-density lipoprotein cholesterol and increased omega-6 polyunsaturated fatty acids in first-degree relatives of bipolar patients. Psychol Med 34(1):103\u2013112. https:\/\/doi.org\/10.1017\/S0033291703001090","journal-title":"Psychol Med"},{"issue":"1","key":"9860_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/0717-6287-47-74","volume":"47","author":"MG Soto-Urquieta","year":"2014","unstructured":"Soto-Urquieta MG, L\u00f3pez-Briones S, P\u00e9rez-V\u00e1zquez V, Saavedra-Molina A, Gonz\u00e1lez-Hern\u00e1ndez GA, Ram\u00edrez-Emiliano J (2014) Curcumin restores mitochondrial functions and decreases lipid peroxidation in liver and kidneys of diabetic db\/db mice. Biol Res 47(1):74. https:\/\/doi.org\/10.1186\/0717-6287-47-74","journal-title":"Biol Res"},{"issue":"1","key":"9860_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jad.2005.12.010","volume":"91","author":"H Tsuboi","year":"2006","unstructured":"Tsuboi H, Tatsumi A, Yamamoto K, Kobayashi F, Shimoi K, Kinae N (2006) Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J Affect Disord 91(1):63\u201370. https:\/\/doi.org\/10.1016\/j.jad.2005.12.010","journal-title":"J Affect Disord"},{"issue":"3","key":"9860_CR63","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","volume":"150","author":"V Valkanova","year":"2013","unstructured":"Valkanova V, Ebmeier KP, Allan CL (2013) CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 150(3):736\u2013744. https:\/\/doi.org\/10.1016\/j.jad.2013.06.004","journal-title":"J Affect Disord"},{"issue":"3","key":"9860_CR64","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jad.2013.05.016","volume":"150","author":"HO Vargas","year":"2013","unstructured":"Vargas HO, Nunes SO, Pizzo de Castro M, Bortolasci CC, Sabbatini Barbosa D, Kaminami Morimoto H, Venugopal K, Dodd S, Maes M, Berk M (2013) Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J Affect Disord 150(3):923\u2013930. https:\/\/doi.org\/10.1016\/j.jad.2013.05.016","journal-title":"J Affect Disord"},{"issue":"4","key":"9860_CR65","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/JCP.0000000000000352","volume":"35","author":"JJ Yu","year":"2015","unstructured":"Yu JJ, Pei LB, Zhang Y, Wen ZY, Yang JL (2015) Chronic supplementation of curcumin enhances the efficacy of antidepressants in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study. J Clin Psychopharmacol 35(4):406\u2013410","journal-title":"J Clin Psychopharmacol"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-017-9860-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9860-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9860-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T05:16:40Z","timestamp":1660281400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-017-9860-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["9860"],"URL":"https:\/\/doi.org\/10.1007\/s12640-017-9860-4","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]}}}